259 related articles for article (PubMed ID: 11475398)
1. Toxicity of the photosensitizer NPe6 following intravitreal injection.
El-Dessouky ES; Moshfeghi AA; Peyman GA; Yoneya S; Mori K; Kazi AA; Moshfeghi DM
Ophthalmic Surg Lasers; 2001; 32(4):316-21. PubMed ID: 11475398
[TBL] [Abstract][Full Text] [Related]
2. Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6).
Mori K; Yoneya S; Ohta M; Sano A; Anzai K; Peyman GA; Moshfeghi DM
Ophthalmology; 1999 Jul; 106(7):1384-91. PubMed ID: 10406627
[TBL] [Abstract][Full Text] [Related]
3. Ocular toxicity of intravitreal tacrolimus.
Passos E; Genaidy MM; Peyman GA
Ophthalmic Surg Lasers; 2002; 33(2):140-4. PubMed ID: 11942546
[TBL] [Abstract][Full Text] [Related]
4. Retinal toxicity of intravitreal 5-fluorouracil in silicone-filled rabbit eyes.
Kivilcim M; Kazi AA; Peyman GA; Hegazy H; El Dessouky el-S; Cheema R; Laghari NA
J Coll Physicians Surg Pak; 2006 May; 16(5):351-4. PubMed ID: 16756781
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal moxifloxacin: retinal safety study with electroretinography and histopathology in animal models.
Gao H; Pennesi ME; Qiao X; Iyer MN; Wu SM; Holz ER; Mieler WF
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1606-11. PubMed ID: 16565399
[TBL] [Abstract][Full Text] [Related]
6. Safety of intravitreal ketorolac and diclofenac: an electroretinographic and histopathologic study.
Kim SJ; Adams NA; Toma HS; Belair ML; Thorne JE; Green WR; Jabs DA
Retina; 2008 Apr; 28(4):595-605. PubMed ID: 18398362
[TBL] [Abstract][Full Text] [Related]
7. Safety of intravitreal voriconazole: electroretinographic and histopathologic studies.
Gao H; Pennesi M; Shah K; Qiao X; Hariprasad SM; Mieler WF; Wu SM; Holz ER
Trans Am Ophthalmol Soc; 2003; 101():183-9; discussion 189. PubMed ID: 14971576
[TBL] [Abstract][Full Text] [Related]
8. Retinal toxicity of commercially available intravitreal ketorolac in albino rabbits.
Komarowska I; Heilweil G; Rosenfeld PJ; Perlman I; Loewenstein A
Retina; 2009 Jan; 29(1):98-105. PubMed ID: 18626418
[TBL] [Abstract][Full Text] [Related]
9. Aclacinomycin A in the treatment of experimental proliferative vitreoretinopathy. Efficacy and toxicity in the rabbit eye.
Steinhorst UH; Chen EP; Hatchell DL; Samsa GP; Saloupis PT; Westendorf J; Machemer R
Invest Ophthalmol Vis Sci; 1993 Apr; 34(5):1753-60. PubMed ID: 8473115
[TBL] [Abstract][Full Text] [Related]
10. Absence of histologic retinal toxicity of intravitreal nanogold in a rabbit model.
Bakri SJ; Pulido JS; Mukherjee P; Marler RJ; Mukhopadhyay D
Retina; 2008 Jan; 28(1):147-9. PubMed ID: 18185152
[TBL] [Abstract][Full Text] [Related]
11. Threshold and retreatment parameters of NPe6 photodynamic therapy in retinal and choroidal vessels.
Peyman GA; Kazi AA; Moshfeghi D; Unal M; Khoobehi B; Yoneya S; Mori K; Rivera I
Ophthalmic Surg Lasers; 2000; 31(4):323-7. PubMed ID: 10928670
[TBL] [Abstract][Full Text] [Related]
12. Long-term retinal toxicity of intravitreal commercially available preserved triamcinolone acetonide (Kenalog) in rabbit eyes.
Albini TA; Abd-El-Barr MM; Carvounis PE; Iyer MN; Lakhanpal RR; Pennesi ME; Chevez-Barrios P; Wu SM; Holz ER
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):390-5. PubMed ID: 17197559
[TBL] [Abstract][Full Text] [Related]
13. Retinal toxicity of commercial intravitreal tissue plasminogen activator solution in cat eyes.
Hrach CJ; Johnson MW; Hassan AS; Lei B; Sieving PA; Elner VM
Arch Ophthalmol; 2000 May; 118(5):659-63. PubMed ID: 10815158
[TBL] [Abstract][Full Text] [Related]
14. Retinal toxicity of intravitreal triamcinolone acetonide at high doses in the rabbit.
Ruiz-Moreno JM; Montero JA; Bayon A; Rueda J; Vidal M
Exp Eye Res; 2007 Feb; 84(2):342-8. PubMed ID: 17141760
[TBL] [Abstract][Full Text] [Related]
15. A pilot study on ocular safety of intravitreal infliximab in a rabbit model.
Giansanti F; Ramazzotti M; Vannozzi L; Rapizzi E; Fiore T; Iaccheri B; Degl' Innocenti D; Moncini D; Menchini U
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1151-6. PubMed ID: 18326743
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal voriconazole: an electroretinographic and histopathologic study.
Gao H; Pennesi ME; Shah K; Qiao X; Hariprasad SM; Mieler WF; Wu SM; Holz ER
Arch Ophthalmol; 2004 Nov; 122(11):1687-92. PubMed ID: 15534131
[TBL] [Abstract][Full Text] [Related]
17. The safety of intravitreal hyaluronidase. A clinical and histologic study.
Gottlieb JL; Antoszyk AN; Hatchell DL; Saloupis P
Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2345-52. PubMed ID: 2242999
[TBL] [Abstract][Full Text] [Related]
18. Administration of novel dyes for intraocular surgery: an in vivo toxicity animal study.
Schuettauf F; Haritoglou C; May CA; Rejdak R; Mankowska A; Freyer W; Eibl K; Zrenner E; Kampik A; Thaler S
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3573-8. PubMed ID: 16877431
[TBL] [Abstract][Full Text] [Related]
19. Vitreoretinal toxicity of acetazolamide following intravitreal administration in the rabbit eye.
Borhani H; Rahimy MH; Peyman GA
Ophthalmic Surg; 1994 Mar; 25(3):166-9. PubMed ID: 8196921
[TBL] [Abstract][Full Text] [Related]
20. Retinal toxicity of intravitreal kenalog in albino rabbits.
Lang Y; Zemel E; Miller B; Perlman I
Retina; 2007; 27(6):778-88. PubMed ID: 17621190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
